Apriglim-MV 303 Tablet SR
By Apriglim-MV
Rx
10 Tablet SR in a Strip

Composition
Glimepiride(3mg) + Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Aprica Pharmaceuticals Pvt Ltd
A/4 4th Floor, Safal Profitaire,Corporate Road,Nr Prahladnagar Garden, Prahladnagar,Ahmedabad- 380015, Gujarat, India.

Expires on or after
October, 2027

liver
When it comes to using Apriglim-MV 303 Tablet SR, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Apriglim-MV 303 Tablet SR. It is advisable to consult your doctor before starting this medication. Typically, Apriglim-MV 303 Tablet SR is initiated at a low dose for individuals with mild to moderate liver disease. However, it is not recommended for use in patients with severe liver disease.

kidney
Apriglim-MV 303 Tablet SR may not be safe for individuals with kidney disease. It is advised to avoid using this medication if you have kidney issues. Consulting with your doctor is recommended. Avoid in severe kidney disease cases.

alcohol
It is not safe to drink alcohol while taking Apriglim-MV 303 Tablet SR.

driving
When your blood sugar levels are too low or high, it can impact your driving ability. Avoid driving if experiencing these symptoms.

pregnancy
It is important to be cautious when using Apriglim-MV 303 Tablet SR during pregnancy. Limited human studies suggest potential harm to the developing baby, as observed in animal studies. Your doctor will evaluate the benefits and risks before prescribing it to you. Please consult your doctor regarding its use during pregnancy.

breastfeeding
Apriglim-MV 303 Tablet SR may not be safe for breastfeeding. Limited data indicates the drug could pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹184.56
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024